![Catherine Bird](/newimages/person-profile/2022b/img-0985-1.x0f841211.jpeg?w=160&h=198&crop=160,160,0,20&f=webp)
Catherine Bird
Senior Clinical Trials Manager
Research interests
- Mental Health
Biography
Catherine works in psychedelic research as part of The Psychoactive Trials Group at The Institute of Psychiatry, Psychology and Neuroscience, King’s College London.
Research
![WhatsApp Image 2024-04-25 at 3.23.03 PM (1)](/newimages/research/thumb/whatsapp-image-2024-04-25-at-3.23.03-pm-1.xfbdc67a3.jpg?width=380&height=215&fit=crop&f=webp)
Psychoactive Trials Group
Psychoactive Trials Group
News
Largest trial to date shows that psilocybin reduces depression symptoms
A new multicentre clinical trial led by COMPASS Pathways across 22 international sites, including the Institute of Psychiatry, Psychology & Neuroscience...
![Spilled medication and bottle](/newimages/folsm/main-article/scps/news/spilled-medication.xaf97435b.png?crop=780,440,0,5&f=webp)
Research
![WhatsApp Image 2024-04-25 at 3.23.03 PM (1)](/newimages/research/thumb/whatsapp-image-2024-04-25-at-3.23.03-pm-1.xfbdc67a3.jpg?width=380&height=215&fit=crop&f=webp)
Psychoactive Trials Group
Psychoactive Trials Group
News
Largest trial to date shows that psilocybin reduces depression symptoms
A new multicentre clinical trial led by COMPASS Pathways across 22 international sites, including the Institute of Psychiatry, Psychology & Neuroscience...
![Spilled medication and bottle](/newimages/folsm/main-article/scps/news/spilled-medication.xaf97435b.png?crop=780,440,0,5&f=webp)